Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Interventional × Advanced NSCLC × Clear all

Phase

Status

Recruiting 5 Terminated 2 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 710 Carcinoma, Non-Small-Cell Lung 480 Prostatic Neoplasms 423 Neoplasms 374 Multiple Myeloma 267 Colorectal Neoplasms 262 Lung Neoplasms 246 Neoplasm Metastasis 237 Melanoma 222 Leukemia, Myeloid, Acute 191 Ovarian Neoplasms 190 Pancreatic Neoplasms 186 Squamous Cell Carcinoma of Head and Neck 165 Lymphoma 147 Recurrence 146 Carcinoma, Renal Cell 145 Glioblastoma 144 Lymphoma, Non-Hodgkin 136 Stomach Neoplasms 130 Brain Neoplasms 130 Triple Negative Breast Neoplasms 129 Head and Neck Neoplasms 127 Leukemia, Lymphocytic, Chronic, B-Cell 123 Carcinoma, Hepatocellular 120 Precursor Cell Lymphoblastic Leukemia-Lymphoma 115 Urinary Bladder Neoplasms 114 Uterine Cervical Neoplasms 109 Sarcoma 108 Lymphoma, Large B-Cell, Diffuse 107 Lymphoma, Follicular 99

Interventions

Oxaliplatin 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04043195 2025-05-28

NSCLC

University of California, San Diego

Phase 1/2 Active not recruiting

Advanced NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡